Application 206881
- Type
- ANDA
- Sponsor
- STRIDES PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 8MEQ | No | No |
| 002 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MEQ | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206881-001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | ||
| A206881-002 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206881-001 | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A206881-002 | POTASSIUM CHLORIDE | 10MEQ | TABLET, EXTENDED RELEASE / ORAL | 2019-01-22 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A206881-001 | AB2 | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A206881-002 | AB2 | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Tris Pharma Inc | 159ddd0b-847e-4ecc-b3b2-9634cbb4dfa9 | 2022-01-26 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Guardian Drug Company | 3d460e84-27a0-485c-8b11-58d03d9064aa | 2021-07-28 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Aurobindo Pharma Limited | deb6b462-397f-4527-ae26-40dc5d5857bc | 2021-04-30 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Aurobindo Pharma Limited | d43beabe-b801-4319-ad36-9a80856b94bd | 2021-04-29 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| potassium chloride | POTASSIUM CHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 51586c47-1aff-4ce6-8030-89f9eb1bc9ac | 2021-02-08 | Warnings, Adverse reactions | potassium chloride POTASSIUM CHLORIDE |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 28c49165-d8c9-443a-b000-953b8e1ec55c | 2020-11-20 | Warnings, Adverse reactions | POTASSIUM CHLORIDE POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences Inc. | 23d818e7-c076-40de-8dc1-0b51ba4be96a | 2020-04-28 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 1bbacdbb-91fa-4897-a00c-1b293de27b83 | 2020-04-27 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | BluePoint Laboratories | 431ff2ef-567c-4b60-af43-f4da61febaad | 2019-07-03 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE EXTENDED-RELEASE | Solco Healthcare LLC | f704b746-ab75-4484-8704-5baa94a07750 | 2019-04-30 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Novel Laboratories, Inc. | ce4d4d39-8551-4789-8347-af763635922c | 2018-11-28 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Northstar Rx LLC | dded25a9-3df4-463a-8685-d2bc03ea4edb | 2018-07-16 | Warnings, Adverse reactions | Potassium Chloride POTASSIUM CHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.